Cooperative Agreement NU50CK000593

This $2,024,907.00 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "STRUCTURE-GUIDED DEVELOPMENT OF POTENT PFPKG INHIBITORS FOR MALARIA CHEMOPROTECTION" project led by Rutgers, The State University of New Jersey (Rutgers), doing business as RBHS-School of Nursing. The project aims to conduct research and development to create new malaria prevention treatments. As the prime awardee, Rutgers...

Rainelle Medical Center (RMC), a Federally Qualified Health Center in rural West Virginia, received a $600,000 Project Grant award effective September 1, 2025, through August 31, 2026, from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912). The award supports RMC's Rural Communities Opioid Response Program–Overdose Response (RCORP-OR) initiative to expand and enhance substance use disorder (SUD) prevention, harm reduction, treatment, and...

Summary of Cooperative Agreement Award The New Mexico Department of Health (NMDOH) Scientific Laboratory Division received a Cooperative Agreement from the Food and Drug Administration (FDA) under the Food and Drug Administration Research program (CFDA 93.103) to conduct retail meat surveillance for antimicrobial resistance. Awarded on September 20, 2025, with $180,000 obligated and a completion date of August 31, 2030, this program provides critical surveillance of antimicrobial-resistant...

The University of Rhode Island (URI) was awarded a $117,696 Cooperative Agreement by the U.S. Department of the Interior U.S. Geological Survey's Research and Data Collection program (CFDA 15.808) to develop frameworks for structured decision-making in tick and tick-borne disease management in New England. The key products and services to be delivered under this award include: Consolidating scientific knowledge on tick control and management into an accessible database for vector management...

The Department of Defense's Defense Health Agency awarded a $1,330,054 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of California, San Francisco (UCSF). The grant supports the "CLINICAL VALIDATION AND IMPLEMENTATION OF A HOST-PATHOGEN-BASED DIAGNOSTIC ASSAY FOR EARLY LYME DISEASE AND OTHER TICK-BORNE INFECTIONS" project, with a performance period from July 1, 2024 to June 30, 2027. As a leading academic medical...

Federal Project Grant Award Summary The Research Foundation For Mental Hygiene, Inc. (RFMH), through its New York State Psychiatric Institute division, received a $524,998 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a nationwide study of suicide and suicidal behaviors among U.S. veterans following Lyme disease diagnosis. The three-year award period runs from September 1, 2025, through August 31, 2028. The...

Federal Project Grant Award Summary The University of Connecticut Health Center received a $457,875 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. The award supports biomedical research investigating the role of the RpoS (sigma factor) regulatory protein in the persistence of Borrelia burgdorferi, the spirochete bacterium that causes...

Federal Grant Award Summary Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a Project Grant award of $506,415 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 9, 2026, with a completion date of January 31, 2028. The research project investigates the pre- and post-exposure prophylaxis of tick-transmitted babesiosis using tafenoquine, an...

The Department of the Army Medical Command awarded a $1,157,298 cooperative agreement to The Geneva Foundation of Tacoma, WA from September 1, 2022 through August 31, 2025. The award will support research under the Military Medical Research and Development program (CFDA 12.420) to rationally design an immunogen for protection against Plasmodium vivax malaria. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...

This $260,109 cooperative agreement from the Uniformed Services University of the Health Sciences will support surveillance for Rift Valley fever, rickettsia, malaria, dengue, chikungunya, and Crimean-Congo hemorrhagic fever disease pathogens. The Henry M. Jackson Foundation for the Advancement of Military Medicine will collect human samples and arthropod vectors from selected sites in Botswana to test for these pathogens. Under a subaward, Virginia Polytechnic Institute and State University...